Ramsey Baghdadi
Latest From Ramsey Baghdadi
Go Beyond The Vial: Medicare Policy Experts Urge Big Thinking On Drug Pricing
NASEM is expected to issue a highly anticipated report in early 2021 on solutions to address Rx vial drug wastage.
US FDA’s Career Leaders Quietly Emerge As Effective Operators In COVID-19 Response
FDA medical review leaders have been remarkable on balancing the two challenges of finding treatments for COVID-19 and keeping everything else running on time.
COVID-19 And The Future Of Rx Pricing Policy: An Interview With White House Advisor Grogan
White House Domestic Policy Council Director Joe Grogan is departing at the end of May. In an interview, he talked about lessons (so far) from the COVID-19 response and the future of drug pricing policy against the backdrop of the pandemic.
Medicare-For-Hmmm: A Year Of House Hearings Show Democratic Disunity
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.
US FDA's New Neurology Leadership Likely To Face Two Big Reviews In 2020
Eric Bastings will lead Division of Neurology I, which is expected to handle Biogen’s Alzheimer’s drug aducanumab and Sarepta’s refiling of golodirsen for DMD next year.
For Biopharma, There May Be Only One Race To Watch In 2020
Senate Majority Leader McConnell is the one constant keeping drug price controls from gaining any legislative traction.